Filing Details
- Accession Number:
- 0001127602-24-006252
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-22 15:04:06
- Reporting Period:
- 2024-02-21
- Accepted Time:
- 2024-02-22 15:04:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453524 | P. Jonathan Divincenzo | 531 South Spring Street Burlington NC 27215 | Evp, Pres, Central Labs & Intl | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-21 | 500 | $215.49 | 3,401 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price of $215.4901 per share represents a weighted average of sales prices ranging from $215.46 to $215.55 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholderof the issuer, full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
